Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
37 Cards in this Set
- Front
- Back
Autosomal dominant
|
heterozygous state. no skip generation, no sex preference, when affected person marries normal person, each child w/ 50% chance develop disease, some affected individuals do not have affected parents -> owe disorder to new mutation either involving egg or sperm
*displays incomplete penetrance, variable expressivity *new mutations, siblings not affected |
|
Autosomal recessive
|
-skip generation, no sex prediction, each child has 1/4 chance of being affected, consanguinity common among parents of affected children , gene should be present in "double dose"
*parents are usually carries of disorders, normally in reg. population trait is not shown -manifested in homozygote stage, need double dose to express conditions *complete penetrance common, onset freq early in life, expression of defect more uniform, in new mutations, ind affected is Asxtic |
|
Incomplete penetrance
|
ability of persons carrying abnormal gene NOT to express trait, inherit gene but phenotypically normal, they can pass gene to offspring who may then have condition
|
|
variable expressivity
|
difference in w/c trait is expressed by persons carrying the gene, some carrying abnormal gene may be affected like
-mild condition -classic features -severe conditions new mutations → siblings not affected delayed age onset not until adulthood |
|
Sex-linked dominant
|
no skip generation, w/ sex predilection, affected males transmit to all daughters, not sons, affected females transmit to half her sons and half her daughters
|
|
Sex-linked recessive:
|
Mutation in X chrom
-skip generation, presence sex predilection, affected male does not transmit to sons, all daughters carriers -carriers transmit 50% to sons, unaffected males never transmit the gene -gene is only needed in single dose to manifest bc other chromosome doesn't have complement necessary for inhibition of x chrom |
|
Sex linked disorders in general
|
all x linked, almost all are x-linked recessive, only gene assigned w/ certainty to Y chrom is determinant for testes, males w/ any mutation on Y-linked genes usually infertile, hence no Y-linked inheritance
|
|
Point mutation
|
affect only a single base
UGA, UAG, UAA-stop codons you are gone, you are away, you go away -nonsense- stops and protein no longer develops- thalassemia-absent globin chain |
|
Mendelian disorders
|
Results of expressed mutation in single genes of large effects
Categories: -defects in structural proteins -defects in receptor proteins -enzyme defects |
|
Enzyme defects
|
1) Accumulation of substrate→accum intermediates (galactosemia)
2) ↓ amt important end product thru missing enzyme –albinism 3) Failure to inactive tissue damaging substance-alpha antitrypsin deficiency |
|
Pleiotropism
|
Single gene mutations leading to many end effects
Eg sickle cell anemia- defect in hemoglobin |
|
defects in receptor/transport sys
|
1) Receptor mediated endocytosis=familial hypercholestemia
2) Transport protein=cystic fibrosis |
|
deletions/insertions
|
frameshift-change seq of a.a., insert or remove more than 3, every time base read, a.a. entirely different
3-base deletion = missense mutation, add or delete on 3 bases, only single group of a.a will be changed-sickle cell anemia |
|
Biochemical mechanism autosomal dominant
|
1) loss of fxn - loss of protein
2) gain of fxn mutation |
|
loss of fxn mutation- autosomal dominant
|
enzyme protein- heterozygotes normal, reduced enzyme # lead to enough # for normal fxn
-non-enzyme protein ----- regulatory protein ex familial hypercholesterolemia reduced syn/fxn of LDL receptors defective transport LDL into cells secondary to excessive cholesterol synth by complex intermediary mechanism ------ structural proteins ex collage -> EDS, fibrillin-> marfan, spectri -> spherocytosis |
|
gain of fxn mutation-auto dom
|
result in new proteins that are usually toxic
*most mutations lead to loss of gene products and to lesser extent, gain of fxn mutation, transmission disorder produced by gain fxn mutations and almost always autosomal dominant |
|
marfan's syndrome
|
deficient or abnormal fibrillin ( - to bone growth and) 15q21.1,
skeletal abnormalities: -unusually tall, ratio of upper to lower is low, long extremities, long head, deformities in chest/spine, loose jointedness, ocular change, cvs lesions, skin |
|
fibrillin
|
maj component extracellular glycoprotein provides framework for elastin -abundant in tendons, bv, lens) and inhibits TGF in bones
FBN1 = marfans aka fibrillin 1, m FBN2 at 5q23.31 = congenital contractual arachnodactylyl |
|
Ocular change in marfan
|
Ectopia lentis-bilateral, up or down dislocation of lens
Severe myopia Retinal detachment |
|
Cvs lesions marfan
|
Mitral valve prolapse, cystic mediionecrosis-aortic dilatation of ascending aort****
|
|
ehler-danlos syndrome
|
EDS
-defective collagen -affects joints, skin, small BV -skin extremely stretchable , fragile, prone to trauma, joints hypermobile-extend many ways -shows molecular heterogeneity -> clinically variable disorder w/ several patterns of inheritance **lysyl hydroxylase deficiency-enzyme for hydroxylation of lysine residues in collagen synthesis |
|
familial hypercholesteremia
|
(19) 1/500
-inc cholesterol in blood stream, genetically determined -loss of inhibitory mechanism, activation of scavenger system - ↓ or defective receptors, receptor d/s due to mutation in gene encoding receptor for LDL (transport/metab cholesterol) + scavenger system |
|
2 mechanisms familial hypercholesteremia
|
1) dec receptor: LDLS cleared thru liver 80%, muscle, adrenals, scavenger pathway exists-mo and lymph, if no receptor for IDL = leads to severe cholesterol elevation
2) loss of inhibitory mechanism- HMG coA inhibit cholesterol prod, acetly coA stimulate storage, esterification, inhibit LDL receptors |
|
Clinical manifestation F- hyperchol
|
Xanthoma formation, atherosclerosis
|
|
Molecular genetics F-hyperchol
|
manifests in- genetic insertions, missense, variable mutiation affecting different aspects of receptor prod and activity- production, transportation, attachment, enclosure
-delestions, insertions, missense ****autosomal dominant pattern inheritance |
|
Autosomal recessive biochemical mechanisms
|
1) Enzyme defect: accumulation abnormal substance, ↓ amt impt end product, failure to inactivate tissue damaging substance
2) Defects in non enzyme protein: transport protein (thallassemia), hemostasis, structural protein |
|
albinism
|
inability to synthesize melanin, absent Tyrosinase enzyme-converts DOPA to melanin, enzyme defect → metabolic block, ↓ amt end product for fxn
*autosomal recessive |
|
Clinical significance albinism
|
1) inc sensitivity to solar exposure, wrinkles, solar keratosis, squamous cell carcinoma
2) impaired visual acuity |
|
Alkaptonuria-ochronosis
|
Inborn error or metabolism, lack of homogentisic oxidase -> inc homogenistic acid w/c binds to CT staining them blue black
-tissues or eyes look blue/black like bruised-ears, nose, cheeks **conseqeuence of deposits of pigment in articular cartilages of joints → lose normal resilency and become brittle, fibrillated Homogenistic oxidase enzyme converts homogentisic acid to methylacetoacetic acid in tyrosine degradation pathway clin sig: cartilage brittle, degenerative neuropathy *autosomal recessive |
|
lysosomal storage diisease
|
Grp disorders w/ lack or abnormality of protein essential for normal function of lysosomes- intracellular digestive track, many hydrolytic enzymes
-glycogenosis, mucopolysaccharidoses, sphingolipidosis, tay sachs, sulfatidoses, neimann-pick d/s |
|
Glycogenosis
|
pompe-generalized, ex: glycogen storage in all organs but cardiomegaly prominent, def acid maltase, lysosomal storage of glyc
myopathic-McArdle's disease ex: ms cramps after exercise, skeletal ms ms phosphoryalse, phosphofructokinase, ↑ lactate hepatic form-von Gierke's dis- hepatomegaly and renomegaly hypoglycemia, hyperlipidemia, hyperuricemia, liver impt-storage, glu 6 phosphatase deficient: lysosomal glucosidase – accumulates glycogen |
|
Sphingolipidosis
|
Tay Sachs-aka Sandhoff d/s, lack enzyme hexosaminidase-build up gangliosides in CNS, AND, retina-> destruction neurons
LM: ballooned neurons, cytoplasmic vacuoles EM: whorled gangliosides in lysosomes clinical pic-ssx @ 6 months, progressive motor and mental deterioration, vegetative in 2, death 3 background of retina- light, macula looks like cherry red spot in tay sachs bc of the light colored background neurons-ballooned w/ cytoplasmic vacuoles, lysosome filled ganglioside beta galactosidase, accum ganglioside |
|
sulfatidoses
|
Gaucher's disease, niemann-picks
|
|
Gaucher’s d/s
|
lack glucocerebrosidase, accumulates glucocerebrosides-gaucher cell, location in chrom 1q21
-most common lysosomal storage disorder -enzyme usually cleaves glucose residue from ceramide, def→ accumulates in phagocytes Type 1-99%, storage glucocerebrosides limited to mononuclear phagocytes throughout body w/out brain mostly spleen/skeletal |
|
Niemann pick d/s
|
-type b-organomegaly w/o CNS involvement, live to adulthood, majority have this
type a- progressive infantile neurologic involvement and marked visceral enlargement, death 2 yrs, missense mutation –SPLEEN ENLARGED type c- defective cholesterol transport from plasma, heterogeneous clinical pic- still birth, neonatal hepatitis, chronic neurologic-NPC1 involved in transport freee chol from lysosome→cytoplasm (more common than a+b) Lack sphingomyelinase accumulate sphingomyelin – component of cellular membranes, deficiency blocks degradation of lipid Chrom 11p15.4 |
|
single gene disorder w/ non classic inheritance
|
1) Triple repeat mutation
2) Mutations in mitochondrial genes 3) Genomic imprinting 4) Gonadal mosaicism |
|
triple gene mutations
|
-expansion of a stretch of nucleotides from numerous repeats
CAG repeat- huntington’s chorea, GAA- freidrichs ataxia, Fragile x= CGG ACC CGG CGG CGG CAG GAA CTG -tendency of expansion depends upon sex of transmitting parent -similar to sex linked recessive except w/ these patterns: 1) presence of carrier males 2) female transmission > carriers fem can transmit to affected daughters, > 30-50% carriers’ affected 3) ANTICIPATION- clinical features worsen and d/s occurs w/ generation |